Surgipharm
Surgipharm Uganda Limited is a Kampala-headquartered pharmaceutical and medical supplies distributor founded in 1997, importing and distributing 600+ products from 40+ international manufacturers to hospitals, government health organisations, NGOs, wholesalers and retailers across Uganda and Rwanda.
- Company typePrivate
- Founded1997
- HeadquartersKampala, Uganda
- Headcount101–250
- GTM typeB2B
- OfferingServices
What Surgipharm does
Surgipharm Uganda Limited is a privately held pharmaceutical and medical supplies distributor founded in 1997 and headquartered in the Ntinda Industrial Area of Kampala, Uganda. The company imports, exports, distributes and markets a diversified health product portfolio organised across eight segments: branded pharmaceuticals, generic pharmaceuticals, OTC pharmaceuticals, FMCG, surgical procedures, diagnostics and medical systems, hospital consumables, and veterinary products. Its portfolio comprises over 600 items sourced from more than 40 international manufacturers including GlaxoSmithKline, Novartis, Roche, Bayer, Sanofi, MSD, Becton Dickinson, Smith & Nephew and Medtronic, distributed across Uganda and Rwanda from cold chain storage facilities in Kampala.
The operating model is B2B enterprise field sales, with dedicated Medical Representative teams selling into government health facilities, NGOs, hospitals, research institutions, large wholesalers and retailers through a tender-based procurement process that the company treats as a core activity. Revenue is generated through product distribution (transactional margins), special procurement services for institutional clients, and value-add services including medical training, health consulting, equipment installation and maintenance, technical consulting and after-sales support, plus 24-hour emergency supply availability. ISO 9001 certification via IQNet supports tender prequalification and quality assurance.
Strategically, Surgipharm is integrated into several donor-funded and government public health programs in Uganda, including the ARV Access For Africa (AA4A) initiative with i+solutions and the Dutch Government, the Affordable Medicines Facility - Malaria (AMFM) as a first-line buyer for the Global Fund, and the Consortium For ACT Private Sector Subsidy (CAPSS) with Medicines for Malaria Venture and the Ugandan Ministry of Health. The company is a privately held Ugandan private limited company with no disclosed parent, investors, funding rounds, revenue figures, or public management roster; ownership and shareholder structure constitute a material data gap.
Surgipharm firmographics
Firmographics- Name
- Surgipharm
- Legal name
- Surgipharm Uganda Limited
- Website
- https://surgipharm.co.ug
- Company type
- Private
- Founded year
- 1997
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Surgipharm Uganda Limited is a Kampala-headquartered pharmaceutical and medical supplies distributor founded in 1997, importing and distributing 600+ products from 40+ international manufacturers to hospitals, government health organisations, NGOs, wholesalers and retailers across Uganda and Rwanda.
- Ownership category
- akta.pro rank
Surgipharm industry classification
Industry- Product category
- Pharmaceutical Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (4242), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047), Surgical & Medical Instruments & Apparatus (3841), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor) (HLAIAJAF)
- akta.pro secondary industries
- Medical Supplies & Consumables Wholesale (Non-Device) (CRAOAHAE), Health Supply Chain, Procurement & Access to Medicines (BPADAIAI), Vaccines & Public Health Product Distribution (CRAOAHAI), OTC Medicines & Consumer Health Products Distribution (CRAOAHAB), Pet Health & Wellness Distribution (Supplements, OTC, Preventives) (CRAOAKAC)
Keywords
Where Surgipharm is headquartered
LocationHeadquarters
- HQ city
- Kampala
- HQ country
- Uganda
- HQ region
- Africa
Offices2 records
Markets served
Surgipharm business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical Distribution: Importation, exportation, distribution and marketing of pharmaceutical products including branded pharmaceuticals, generic pharmaceuticals, OTC products, FMCG, surgical products, diagnostics equipment, hospital consumables, and veterinary products. Revenue generated from product sales through distribution network covering Uganda and Rwanda.
- Professional Services: Medical training programmes, health consulting services, equipment installation and maintenance, technical consulting, and after-sales support services offered to customers.
- Special Procurement Services: Tender-focused procurement services for institutional customers, including development and review of procurement plans, documentation preparation, and supply of broad range of products at competitive prices.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Quote-based pricing for institutional and retail customers |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels5 records
Surgipharm product offering
Product offeringCore offering
Surgipharm imports, exports, distributes, and markets pharmaceutical products, medical devices, diagnostics, surgical supplies, hospital consumables, OTC medicines, FMCG health products, and veterinary medicines across Uganda and Rwanda. The portfolio covers more than 600 items sourced from 40+ international manufacturers, supported by cold-chain storage, equipment installation and maintenance, training, consulting, and special procurement services for institutional customers.
Product overview
Surgipharm Uganda Limited operates as a pharmaceutical and diagnostics supply company with a diversified portfolio spanning eight business segments: Branded Pharmaceuticals (from GlaxoSmithKline, Novartis, Roche, Bayer, Sanofi, MSD, Adcock Ingram, Besins, Merck, Organon), Generic Pharmaceuticals, OTC Pharmaceuticals, Fast Moving Consumer Goods, Surgical Procedures (including Smith & Nephew orthopaedic products), Diagnostics & Medical Systems (Hemocue, NIHON KOHDEN, BECKMAN COULTER), Hospital Consumables, and Veterinary Products. Their product portfolio consists of over 600 items from over 40 international pharmaceutical and medical supply companies. Complementing their product offerings, they provide related services including Medical Training, Health Consulting, Equipment Installation & Maintenance, Special Procurement Services, Technical Consulting, and After Sales Support. The company distributes throughout Uganda and Rwanda.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- Over 600 product items available
- +2 more outcomes
Companies that use Surgipharm
Customer profileNamed customers6 records
Segments6 records
Ideal customer profiles4 records
Surgipharm technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Surgipharm partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core.
- i+solutionscoreJoint venture partner in ARV Access For Africa (AA4A) initiative with i+solutions and the Dutch government. The partnership aims to improve access to quality healthcare services in Uganda through provision of buffer stock of antiretroviral (ARV) drugs supplied to organisations at not-for-profit prices.
- Dutch GovernmentcoreFunding and support partner in ARV Access For Africa (AA4A) initiative to improve access to antiretroviral drugs in Uganda through not-for-profit pricing.
- Medicines for Malaria Venture (MMV)coreSwiss not-for-profit public-private partnership participant in Consortium For ACT Private Sector Subsidy (CAPSS) with Ugandan Ministry of Health to provide highly subsidised and repackaged artemisinin-based combination therapies (ACTs) through private sector in four districts in eastern Uganda.
- Global FundcoreHost and manager of Affordable Medicines Facility - Malaria (AMFM), an innovative financing mechanism designed to expand access to the most effective malaria treatment (ACTs). Surgipharm is a first line buyer for Uganda working with manufacturers to avail subsidised ACTs.
- Ugandan Ministry of HealthcoreGovernment partner in multiple initiatives including National Injection Safety Campaign, Consortium For ACT Private Sector Subsidy (CAPSS), and various health programmes. Represents the company in national health policy implementation.
- Becton DickinsoncorePartnership in National Injection Safety Campaign working to reduce transmission of communicable diseases through stocking and availing innovative syringes and sharps collector products through policy implementation and sensitising programmes.
- Smith & NephewcorePartnership for orthopaedic and spinal procedures focusing on introduction and facilitation of modern procedures through hands-on training and investment in requisite implants and instrumentation.
- MedtroniccorePartnership with Smith & Nephew focusing on orthopaedic and spinal procedures including hands-on training and investment in implants and instrumentation resulting in lower end-user costs.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
Surgipharm competitors and assessment
Company assessmentEmerging players
- mPharma: mPharma is a Ghana-headquartered, venture-backed healthcare company that operates pharmacy retail and pharmaceutical distribution across multiple African countries and is expanding into Uganda and neighboring markets. It overlaps with Surgipharm in pharmaceutical distribution and supplier relationship management for branded and generic medicines in sub-Saharan Africa.
Broad incumbents
- Cipla: Cipla is one of India's largest pharmaceutical manufacturers with established distribution operations across Africa, including branded ARVs and generics in Uganda. It is comparable to Surgipharm as both a supplier principal and an indirect competitor in branded and generic pharmaceutical distribution across East Africa.
- Novartis (Sandoz Division): Novartis and its Sandoz generics division operate commercial pharmaceutical distribution in East Africa, including branded and generic medicines in Uganda. It is comparable to Surgipharm both as a multinational principal whose products Surgipharm distributes and as a broader pharma player operating in the same regional pharmaceutical market.
Direct peers
- Imperial Health Sciences: Imperial Health Sciences, part of Imperial Group, is the largest pharmaceutical and FMCG wholesaler in East and Southern Africa, operating cold-chain distribution across Kenya, Uganda, Tanzania, and beyond. It directly competes with Surgipharm in pharmaceutical and medical supplies wholesale distribution in Uganda and Rwanda, with a comparable multi-segment portfolio and government/institutional customer base.
- Beta Healthcare International: Beta Healthcare International is a Kenya-based pharmaceutical manufacturer and distributor with a broad portfolio across branded pharma, OTC, FMCG, and veterinary products across East Africa. It is comparable to Surgipharm as a multi-segment East African pharma player serving both institutional and retail channels.
- Medsource Group: Medsource is a pharmaceutical and medical supplies wholesaler operating across East Africa, supplying hospitals, pharmacies, and NGOs with branded and generic medicines. It is comparable to Surgipharm in target customer mix (institutional/NGO/government) and product breadth across pharmaceutical and medical consumables in the East African region.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Surgipharm social profiles
Digital presenceSurgipharm compliance and trust
Trust signalCompliance1 record
Surgipharm financial estimates
Financial estimateRevenue estimate
Valuation estimate
Surgipharm leadership team
Management profileNumber of profiles
Surgipharm funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Surgipharm M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Surgipharm
What does Surgipharm do?
Surgipharm imports, exports, distributes, and markets pharmaceutical products, medical devices, diagnostics, surgical supplies, hospital consumables, OTC medicines, FMCG health products, and veterinary medicines across Uganda and Rwanda. The portfolio covers more than 600 items sourced from 40+ international manufacturers, supported by cold-chain storage, equipment installation and maintenance, training, consulting, and special procurement services for institutional customers.
Is Surgipharm a public or private company?
Surgipharm is a private company. It is classified as unknown and is currently operating.
When was Surgipharm founded?
Surgipharm was founded in 1997. It employs 101 to 250 people.
Where is Surgipharm based?
Surgipharm is headquartered in Kampala, Uganda, in the Africa region.
How does Surgipharm make money?
Three revenue lines are on record. Pharmaceutical Distribution is the primary driver. The others are professional Services and special Procurement Services.
Who are Surgipharm's main competitors?
mPharma is listed as an emerging player. Broad incumbents are Cipla and Novartis (Sandoz Division). Direct peers are Imperial Health Sciences, Beta Healthcare International and Medsource Group.
Does Surgipharm have an API?
No public API is recorded for Surgipharm.
What industry is Surgipharm in?
Surgipharm's product category is Pharmaceutical Distribution. Its primary akta.pro industry code is HLAIAJAF, Government & Public-Sector Pharmaceutical Supply (Tender/Prime Vendor), with a secondary code of CRAOAHAE, Medical Supplies & Consumables Wholesale (Non-Device). Its NAICS code is 4242 and its SIC code is 5122.